Link, study suggests
AGLP-1 Drugs: A Promising Weapon Against Obesity-Related Cancers? A groundbreaking American study involving over 1.6 million patients with type 2 diabetes has revealed a potential game-changer in the fight against obesity-associated cancers. Researchers found that individuals taking GLP-1 agonists, a class of drugs primarily used to manage diabetes, experienced a significant reduction in the risk … Read more